1 / 43

Antibody Detection & Identification Review

Antibody Detection & Identification Review. CLS 423 Clinical Immunohematology Advanced Antibody Identification Module. Objectives. After viewing this presentation, the student will be able to: Apply appropriate exclusion/inclusion techniques to antibody identification

ila-golden
Download Presentation

Antibody Detection & Identification Review

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Antibody Detection & Identification Review CLS 423 Clinical Immunohematology Advanced Antibody Identification Module

  2. Objectives After viewing this presentation, the student will be able to: • Apply appropriate exclusion/inclusion techniques to antibody identification • Select cells to be tested in order to complete an antibody identification • Prove within 95% confidence that the antibody identification is correct • Select appropriate positive and negative controls for antigen typing

  3. Antibody Screen Results • Assume that testing was performed using the tube technique with LISS enhancement. • Immediate spin (IS) and 37oC phases showed no reactivity with all 3 screen cells. • Coombs Control Cells (CC) added to tubes II and III after the AHG phase were 2+ positive.

  4. How would you interpret the results of the antibody screen? • Positive • Negative • Unable to interpret (Click on one of the buttons to register your choice)

  5. How would you interpret the results of the antibody screen? • Positive • Negative • Unable to interpret CORRECT! Click here to continue

  6. How would you interpret the results of the antibody screen? • Positive • Negative • Unable to interpret Incorrect. The antibody screen in this case is positive. (3+ reaction with screen cell I)

  7. What is the next appropriate step? • Antigen type patient’s red blood cells • Perform a panel using patient’s plasma or serum • Repeat the screen using prewarmed patient’s serum and screen cells • No additional testing is necessary (Click on one of the buttons above to register your choice)

  8. No additional testing is necessary Sorry…there is more work to be done to resolve this case. Click here to review the other options

  9. Antigen Type Patient’s RBCs • This step is premature. • The antibodies should be identified first. • Which action would you like to take? • Perform a panel • Repeat the screen using prewarmed technique • No additional testing is necessary (Click on one of the buttons above to register your choice)

  10. Prewarm Technique • This action is not appropriate in this case. • There is no evidence of interference from a cold antibody. • Which action would you like to take? • Antigen type patient’s red blood cells • Perform a panel • No additional testing is necessary

  11. Perform a Panel • This would be the most useful step to take next in resolving this case.

  12. Initial Panel

  13. “THE RULES” • Exclude using only cells that failed to react with the serum (negative) • Exclude an antibody when the cell has homozygous antigen expression • Exceptions: • K, Kpa, Jsa, and Lua can be ruled out when they are present on a cell with heterozygous or homozygous expression • If anti-D is in the plasma, then C and E can be excluded using a cell with heterozygous expression • If anti-D is not in the plasma, C and E must be ruled out using a cell with homozygous antigen expression

  14. Find a cell with … • Homozygous expression of E • 3

  15. Find a cell with … • Heterozygous expression of M • 2, 4, 5, 6, 9

  16. Homozygous vs. Heterozygous • Homozygous – only one allele of the pair is present on the cell • C + c - • Heterozygous – both alleles of the pair are present on the cell • C+ c+

  17. Initial Panel Results Take a moment to determine what antibodies can be excluded based on the results of the initial panel.

  18. Initial Panel Results

  19. Initial Panel Results • What antibodies are you unable to exclude? • C, E, Cw, K, Kpa, Jsa, Fyb, Jka, N, S, & Lua • Does any single antibody explain all of the positive results? • NO • What is the significance of the auto control result? • No autoantibodies are present

  20. Can any additional antibodies be excluded based on the antibody screen results? • If so, what are they? • E, Fyb, & N

  21. C, Cw, K, Kpa, Jsa, Jka, S, & Lua have not been excluded • What is the next appropriate step to take in order to complete the antibody identification? • Antigen type the patient’s red blood cells • Fill the rule of 3 & 3 to provide 95% confidence in the antibody identification • Test selected cells to eliminate or confirm the presence of the antibodies that were not excluded from the initial panel • Treat panel cells with enzymes and repeat testing

  22. Antigen type the patient’s RBCs • Antigen typing for this many antigens will be more time consuming than other steps that could be taken. • Antigen typing for this many antigens is generally not cost effective. • Anti-sera for typing some of these antigens (Cw, Kpa, Jsa, & Lua) may not be readily available • What step would you like to take instead? • Fill the rule of 3 & 3 to provide 95% confidence in the antibody identification • Test selected cells to eliminate or confirm the presence of the antibodies that were not excluded from the initial panel • Treat panel cells with enzymes and repeat testing

  23. Fill the rule of 3 & 3 • There are too many antibodies that have not been excluded to begin examining the probability that these reactions are caused by antibodies and not just by random chance. • What step would you like to take instead? • Antigen type the patient’s red blood cells • Test selected cells to eliminate or confirm the presence of the antibodies that were not excluded from the initial panel • Treat panel cells with enzymes and repeat testing

  24. Enzyme Panel • C, Cw, K, Kpa, Jsa, Jka, S, & Lua have not been excluded • C, Cw, and Jka show stronger antigen expression when cells are treated with enzymes • S is destroyed by enzymes • K, Kpa, Jsa, and Lua are unaffected by routine enzymes • May not provide adequate separation of antibodies in this case • There is a better choice for this case • What step would you like to take instead? • Antigen type the patient’s red blood cells • Fill the rule of 3 & 3 to provide 95% confidence in the antibody identification • Test selected cells to eliminate or confirm the presence of the antibodies that were not excluded from the initial panel

  25. Selected Cells • This would be a useful step to take at this point • C, Cw, K, Kpa, Jsa, Jka, S, & Lua have not been excluded • All but Lua are clinically significant • Cw, Kpa, Jsa & Lua are low prevalence antigens. It may be difficult to find cells that are antigen positive to use for exclusion

  26. Selected Cells These cells are available for use in a selected cell panel. Take a moment to decide which cells you would like to test.

  27. The yellow highlighted cells would make a good selected cell panel for this case Other cells on this panel could be run, but would have more overlap in antigens. Additional cells may need to be tested as a result.

  28. Selected Cell Panel

  29. Selected Cell Results • What antibodies are present in this specimen? • Anti-K and anti- Jka • Are there clinically significant antibodies that still cannot be excluded? • Anti- Jsa • Anti-Lua is not excluded, but is generally considered insignificant

  30. What to do when an antibody cannot be excluded? • Type the patient for the antigen. • If the patient is antigen positive, he should not be able to make the antibody. • If the antibody is to a low prevalence antigen (like the anti-Jsa in this case), it may not be possible to exclude it with the available reagents. • In most cases, a compatible antiglobulin crossmatch is considered “proof” that a unit of red blood cells would be safe to transfuse the patient (“crossmatch compatible” blood vs. antigen negative blood) • If the unit was positive for the low prevalence antigen, and the patient had the antibody, the crossmatch should be incompatible. • It may be necessary to send the specimen to a reference laboratory to prove or exclude an antibody to a low prevalence antigen.

  31. List the phenotypes of cells that need to be tested in order to prove this ID with 95% confidence? • 3 cells that are K+ Jka – that react + • 3 cells that are K- Jka + that react + • 3 cells that are K- Jka – that react – • Has this been filled with the cells that have already been tested? • NO • What cells still need to be tested? • Need one more cell that is K+ Jka – that reacts +

  32. What additional step should be taken to confirm this ID? • Absorb out the anti-Jka using a Jka + K- cell to “unmask” the anti-K • Antigen type the patient’s red blood cells • Fill the rule of 3 & 3 • Perform a DAT using the patient’s red blood cells (Click on one of the buttons above to register your choice)

  33. Absorption • Not necessary at this point, since the selected cell panel has already demonstrated these 2 specificities • What other action would you take? • Antigen type the patient’s red blood cells • Fill the rule of 3 & 3 • Perform a DAT using the patient’s red blood cells (Click on one of the buttons above to register your choice)

  34. Rule of 3 & 3 • This is the 95% confidence rule. • If there is a cell available, one more cell that is K+ Jka – should be tested to fill this rule. We would expect this cell to react +. • What other step should be performed? • Absorb out the anti-Jka using a Jka + K- cell to “unmask” the anti-K • Antigen type the patient’s red blood cells • Perform a DAT using the patient’s red blood cells

  35. Perform DAT • Not necessary in this case. • Auto control would have been positive if the patient had a positive DAT. • What other action would you take? • Absorb out the anti-Jka using a Jka + K- cell to “unmask” the anti-K • Antigen type the patient’s red blood cells • Fill the rule of 3 & 3

  36. Antigen Typing • What would be the expected results of antigen typing? • K… • Neg • Jka … • Neg

  37. Using this panel, select positive and negative controls for K antigen typing

  38. K Controls • Positive Control • Cell 2 or 7 • Negative Control • Any of the remaining cells

  39. Using this panel, select positive and negative controls for Jka antigen typing

  40. Jka Controls • Positive • Cell 3, 6, 7, or 11 • Must be heterozygous in order to detect the weakest amount of antigen present • Negative • Cell 2, 4, 5, or 10

  41. How would you prepare packed RBC units for this patient? • Antigen type units for K & Jka • Perform an antiglobulin crossmatch

  42. If the physician ordered 6 units of packed RBCs for this patient, how many units would need to be antigen typed in order to find compatible units? 6/(.33 x .91) = 19.98 # units ordered /(freq. Jka - x freq. K-) Type 20 units to find 6 antigen negative units

  43. The End Please complete the 8 Antibody Identification – Advanced Methods case studies and the assigned TracQ cases.

More Related